About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Onivyde With Fluorouracil and Leucovorin Approved to Treat Advanced Pancreatic Cancer

by Vishnuprasad on October 23, 2015 at 11:46 AM
Font : A-A+

Onivyde With Fluorouracil and Leucovorin Approved to Treat Advanced Pancreatic Cancer

Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin can be used to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy, said the U.S. Food and Drug Administration in a press release on October 22, 2015.

"Many FDA staff who review drug applications are clinicians as well, so it's especially rewarding when we are able to expedite access to new treatments for patients with unmet needs. By using the Priority Review designation for the application for Onivyde, patients will have earlier access to a drug that helps extend survival," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.

Advertisement

The drug regulator granted Priority Review and orphan drug designations for Onivyde. A study demonstrated the effectiveness of Onivyde. The three-arm, randomized, open label study involved as many as 417 patients with metastatic pancreatic adenocarcinoma whose cancer had grown after receiving the chemotherapeutic drug gemcitabine or a gemcitabine-based therapy.

Investigators found that patients treated with Onivyde plus fluorouracil/leucovorin lived an average of 6.1 months, compared to 4.2 months for those treated with only fluorouracil/leucovorin.

The safety of Onivyde was also tested in 398 patients who received either Onivyde with fluorouracil/leucovorin, Onivyde alone or fluorouracil/leucovorin. Merrimack Pharmaceuticals of Cambridge, Massachusetts holds the marketing authority of Onivyde.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Pancreatitis Health Benefits of Dandelion Plant Whippleīs Surgical Procedure Pancreas Transplantation 

Most Popular on Medindia

Iron Intake Calculator Find a Hospital Drug Interaction Checker Turmeric Powder - Health Benefits, Uses & Side Effects Blood Pressure Calculator How to Reduce School Bag Weight - Simple Tips Sinopril (2mg) (Lacidipine) Daily Calorie Requirements A-Z Drug Brands in India Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Onivyde With Fluorouracil and Leucovorin Approved to Treat Advanced Pancreatic Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests